NCT02144935

Brief Summary

Patients and families are invited to participate in an online registry and data repository specifically for patients with transverse myelitis (TM) or acute flaccid myelitis (AFM). The data generated in this study will come from surveys, interviews, review of medical records. Data from this study will be utilized to guide future clinical trials for children with an acute case of TM or AFM. Parents and school aged children will complete an online survey 7 banks of questions. Each bundle of survey topics have 7-10 questions. We will have both the parent and child complete a outcomes based survey within 6 months of diagnosis and invite to participate every 4 months until study end in 2024.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

May 19, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 22, 2014

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 19, 2022

Completed
Last Updated

August 23, 2022

Status Verified

August 1, 2022

Enrollment Period

8.3 years

First QC Date

May 19, 2014

Last Update Submit

August 22, 2022

Conditions

Keywords

pediatrics

Outcome Measures

Primary Outcomes (1)

  • Patient and parent reported symptoms of recovery

    each parent /guardian and child will fill out a questionnaire examining how you feel about your ability to move and your emotions. This is completed at 3,6,and 12 months after symptoms are diagnosed.

    up to one year post symptom onset

Secondary Outcomes (1)

  • ASIA scale

    up to one year after symptom diagnosis

Study Arms (1)

myelitis, transverse or acute flaccid myelitis

Observational study with online survey participation highlighting outcomes recovery. The surveys can be completed by the child and parent, or if too young to participate, parent only. The survey asks how the child is doing after hospitalization within 6 months of diagnosis, and every 4 months until study end in 2024.

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Pediatric Transverse Myelitis. Pediatric Acute Flaccid Myelitis. The diagnosis of TM or AFM needs to be within 6 months of symptom onset at the time of consent.

You may qualify if:

  • Diagnosis of transverse myelitis (TM) or acute flaccid myelitis (AFM)
  • Patient is within 6 months of symptom onset
  • Ability of patent or legal guardian is able to provide informed consent
  • Ability of a child 10 or older able to provide assent
  • Access to the internet

You may not qualify if:

  • Inability to provide appropriate consent or assent
  • Diagnosis of multiple sclerosis, neuromyelitis optica, or neuromyelitis optica spectrum disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UTexasSouthwestern

Dallas, Texas, 75235, United States

Location

Related Links

MeSH Terms

Conditions

Myelitis, TransverseParaplegia

Condition Hierarchy (Ancestors)

MyelitisCentral Nervous System InfectionsInfectionsParaneoplastic Syndromes, Nervous SystemNervous System NeoplasmsNeoplasms by SiteNeoplasmsParaneoplastic SyndromesDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesCentral Nervous System DiseasesSpinal Cord DiseasesDemyelinating DiseasesNeurodegenerative DiseasesNeuroinflammatory DiseasesAutoimmune DiseasesImmune System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Benjamin Greenberg, MD

    UT Southwestern

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

May 19, 2014

First Posted

May 22, 2014

Study Start

May 1, 2014

Primary Completion

August 19, 2022

Study Completion

August 19, 2022

Last Updated

August 23, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations